These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15318545)

  • 1. [The Bethesda system: new revision of the terminology from 2001 year].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2004; 43(4):52-5. PubMed ID: 15318545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of the Bethesda-terminology cytological system in clinical practice. A pilot study].
    Kostova P; Zlatkov V; Zamfirova K; Ganchev G
    Akush Ginekol (Sofiia); 1994; 33(3):26-8. PubMed ID: 7793521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bethesda System 2001: an update of new terminology for gynecologic cytology.
    Henry MR
    Clin Lab Med; 2003 Sep; 23(3):585-603. PubMed ID: 14560530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician attitudes toward the Bethesda System of reporting cervical cytology.
    Ferris DG; Miller MD; Wagner P; Walaitis E
    Fam Pract Res J; 1993 Sep; 13(3):267-73. PubMed ID: 8296590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bethesda System for reporting cervical and vaginal cytologic diagnoses: report of the 1991 Bethesda workshop.
    J Fam Pract; 1992 Jul; 35(1):98-101. PubMed ID: 1613480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is Bethesda system better than Pap classification?].
    Vuopala S
    Duodecim; 1999; 115(18):2030-4. PubMed ID: 11941821
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress report on the Bethesda System].
    Cochand-Priollet B; Ziol M; ; Cartier I; Dubois A; Michiels-Marzais D; Müller J; Picot R; Tartar MD; Vacher-Lavenu MC; Vincent S
    Ann Pathol; 2006 Oct; 26(5):382-8. PubMed ID: 17255927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses.
    Hudson EA; Coleman DV; Brown CL
    Acta Cytol; 1990; 34(6):902-3. PubMed ID: 2256425
    [No Abstract]   [Full Text] [Related]  

  • 9. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop.
    J Reprod Med; 1992 May; 37(5):383-6. PubMed ID: 1354748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pap, Bethesda or something else?].
    Syrjänen K
    Duodecim; 2000; 116(11):1248-50. PubMed ID: 11989011
    [No Abstract]   [Full Text] [Related]  

  • 11. Terminology of the BSCC, European Community and the Bethesda system: the boundary between low-grade and high-grade cytology.
    Herbert A; Gray W; Cross P
    Cytopathology; 2009 Feb; 20(1):3-4. PubMed ID: 19133066
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
    Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
    Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maryland's cytology labs: 1989-90 proficiency testing results.
    DeBoy JM; Jarboe BR
    Md Med J; 1991 Feb; 40(2):107-11. PubMed ID: 1847738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of using the Bethesda system to evaluate vaginal smears. An end of Papanicolaou classification?].
    Wagrowska-Danilewicz M; Danilewicz M
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):191-2, 197. PubMed ID: 8084822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BSCC, Bethesda or other? Terminology in cervical cytology European panel discussion.
    Kocjan G; Priollet BC; Desai M; Koutselini H; Mahovlic V; Oliveira MH; Pohar-Marinsek Z; Sauer T; Schenk U; Shabalova I; Herbert A
    Cytopathology; 2005 Jun; 16(3):113-9. PubMed ID: 15924605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Litigation cells: definition and observations on a cell type in cervical vaginal smears not addressed by the Bethesda System.
    Frable WJ
    Diagn Cytopathol; 1994; 11(3):213-5. PubMed ID: 7867460
    [No Abstract]   [Full Text] [Related]  

  • 18. The cervical Papanicolaou smear: bacterial infection and the Bethesda System.
    Giacomini G; Schnadig VJ
    Acta Cytol; 1992; 36(1):109-10. PubMed ID: 1312284
    [No Abstract]   [Full Text] [Related]  

  • 19. The Bethesda system--the European perspective: report on the Second Conference on the Bethesda System for reporting cervical/vaginal cytological diagnoses.
    Schneider V
    Cytopathology; 1992; 3(1):27-9. PubMed ID: 1348649
    [No Abstract]   [Full Text] [Related]  

  • 20. In search of a "reasonable person standard" for gynecologic cytologists.
    Austin RM
    Diagn Cytopathol; 1994; 11(3):216-8. PubMed ID: 7867461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.